Join
Live feed
·
INSIDERFilingvia Quantisnow
Xeris Biopharma Holdings Inc. logo

Officer Hecht Beth sold $103,805 worth of shares (16,667 units at $6.23) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,193,173 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XERS (Xeris Biopharma Holdings Inc.) and more on Quantisnow.